Cargando…
Sphingosine kinase 1 contributes to doxorubicin resistance and glycolysis in osteosarcoma
Osteosarcoma (OS) is one of the most common and aggressive malignancies in children and adolescents worldwide. Sphingosine kinase 1 (SphK1) has recently been reported to serve a role in OS progression. The present study aimed to investigate the role of SphK1 in the development of chemoresistance and...
Autores principales: | Ren, Xiaojun, Su, Chunhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411368/ https://www.ncbi.nlm.nih.gov/pubmed/32705189 http://dx.doi.org/10.3892/mmr.2020.11295 |
Ejemplares similares
-
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells
por: Giacomini, Isabella, et al.
Publicado: (2023) -
The anti-osteosarcoma cell activity by the sphingosine kinase 1 inhibitor SKI-V
por: Sun, Xu, et al.
Publicado: (2022) -
Sphingosine Kinase-1 Is Overexpressed and Correlates with Hypoxia in Osteosarcoma: Relationship with Clinicopathological Parameters
por: Gomez-Brouchet, Anne, et al.
Publicado: (2022) -
Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer
por: Matula, Kasia, et al.
Publicado: (2015) -
The roles of glycolysis in osteosarcoma
por: Feng, Zuxi, et al.
Publicado: (2022)